ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

Abstract

HomeCirculationVol. 113, No. 5ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial InfarctionA Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non–ST-Elevation Myocardial Infarction) WRITING COMMITTEE MEMBERS Harlan M. Krumholz, MD, FACC, FAHA, Chair, Jeffrey L. Anderson, MD, FACC, FAHA, Neil H. Brooks, MD, FAAFP, Francis M. Fesmire, MD, FACEP, Costas T. Lambrew, MD, MACC, Mary Beth Landrum, PhD, W. Douglas Weaver, MD, FACC, FAHA, John Whyte, MD, MPH, Robert O. Bonow, TASK FORCE MEMBERS:, MD, FACC, FAHA, Chair, Susan J. Bennett, DNSC, RN, FAAN, FAHA, Gregory Burke, MD, MS, FAHA, Kim A. Eagle, MD, FACC, FAHA, Chair, Harlan M. Krumholz, MD, FACC, FAHA, Costas T. Lambrew, MD, MACC, Jane Linderbaum, NP, Frederick A. Masoudi, MD, FACC, FAHA, Sharon-Lise T. Normand, PhD, MSC, FACC, Ileana L. Piña, MD, FACC, Martha J. Radford, MD, FACC, FAHA, John S. Rumsfeld, MD, PhD, FACC, James L. Ritchie, MD, FACC and John A. Spertus, MD, MPH, FACC WRITING COMMITTEE MEMBERS Search for more papers by this author , Harlan M. KrumholzHarlan M. Krumholz Search for more papers by this author , Jeffrey L. AndersonJeffrey L. Anderson Search for more papers by this author , Neil H. BrooksNeil H. Brooks Search for more papers by this author , Francis M. FesmireFrancis M. Fesmire Search for more papers by this author , Costas T. LambrewCostas T. Lambrew Search for more papers by this author , Mary Beth LandrumMary Beth Landrum Search for more papers by this author , W. Douglas WeaverW. Douglas Weaver Search for more papers by this author , John WhyteJohn Whyte Search for more papers by this author , Robert O. BonowRobert O. Bonow Search for more papers by this author , Susan J. BennettSusan J. Bennett Search for more papers by this author , Gregory BurkeGregory Burke Search for more papers by this author , Kim A. EagleKim A. Eagle Search for more papers by this author , Harlan M. KrumholzHarlan M. Krumholz Search for more papers by this author , Costas T. LambrewCostas T. Lambrew Search for more papers by this author , Jane LinderbaumJane Linderbaum Search for more papers by this author , Frederick A. MasoudiFrederick A. Masoudi Search for more papers by this author , Sharon-Lise T. NormandSharon-Lise T. Normand Search for more papers by this author , Ileana L. PiñaIleana L. Piña Search for more papers by this author , Martha J. RadfordMartha J. Radford Search for more papers by this author , John S. RumsfeldJohn S. Rumsfeld Search for more papers by this author , James L. RitchieJames L. Ritchie Search for more papers by this author and John A. SpertusJohn A. Spertus Search for more papers by this author Originally published3 Jan 2006https://doi.org/10.1161/CIRCULATIONAHA.106.172860Circulation. 2006;113:732–761is corrected byCorrectionOther version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 3, 2006: Previous Version 1 TABLE OF CONTENTSPreamble 733I. Introduction 735 A. Scope of the Problem 735 B. Writing Committee Structure/Members 735 C. Independence/Relationships With Industry Disclosure 735 D. Review/Endorsement 735II. Methodology 735 A. Definition of STEMI/NSTEMI 735 B. Dimensions of Care 736 C. Literature Review 736 D. Definition and Selection of Measures 736III. STEMI/NSTEMI Performance Measures 737 A. Inpatient Population and Care Period 737 B. Brief Summary of the Measurement Set 737 C. Data Collection 738IV. Discussion 738 A. Addition of ARBs to ACEI Measure 738 B. Median Versus Mean—Time to Fibrinolytic Therapy and Time to Primary PCI Measures 739 C. New Standard for Time to Primary PCI Measure 739 D. New Reperfusion Therapy Measure 739Appendix A: ACC/AHA STEMI/NSTEMI Measurement Set Specifications 740Appendix B: Sample Rating Form and Guide 754Appendix C: Relationships With Industry—Writing Committee 756Appendix D: Relationships With Industry—Peer Reviewers 757References 760PREAMBLEMedicine is experiencing an unprecedented focus on quantifying and improving health care quality. The American College of Cardiology (ACC) and the American Heart Association (AHA) have developed a multi-faceted strategy to facilitate the process of improving clinical care. The initial phase of this effort was to create clinical practice guidelines that carefully review and synthesize available evidence to better guide patient care. Such guidelines are written in a spirit of suggesting diagnostic or therapeutic interventions for patients in most circumstances. Accordingly, significant judgment by clinicians is required to adapt these guidelines to the care of individual patients, and these guidelines can be generated with varying degrees of confidence based upon available evidence. Occasionally, the evidence supporting a particular structural aspect or process of care is so strong that failure to perform such actions reduces the likelihood that optimal patient outcomes will occur. Creating a mechanism for quantifying these opportunities to improve the outcomes of care is an important and pressing challenge.In the next phase of its quality improvement efforts, the ACC and the AHA created the ACC/AHA Task Force on Performance Measures in February 2000 to spearhead the development of performance measures that allow the quality of cardiovascular care to be assessed and improved. Three nominees from each organization were charged with the task of assembling teams of clinical and methodological experts, both from within the sponsoring organizations and from other organizations dedicated to the care of patients covered by the performance measurement set. These writing committees were given careful guidance with respect to the necessary attributes of good performance measures and the process of identifying, constructing, and refining these measures so that they can accurately achieve their desired goals (1).The role of performance measurement writing committees is not to perform a primary evaluation of the medical literature; this is undertaken by ACC/AHA guidelines committees. However, performance measurement writing committees work collaboratively with guidelines committees so that the guideline recommendations are written with a degree of specificity that supports performance measurement and so that new knowledge can be rapidly incorporated into performance measurement. Development of ACC/AHA guidelines includes a detailed review of and ranking of the evidence available for the diagnosis and treatment of specific disease areas. Published guideline recommendations employ the ACC/AHA classification system I, IIa, IIb, and III (Fig. 1).So as not to duplicate performance measure development efforts, writing committees were also instructed to evaluate existing nationally recognized performance measures using the ACC/AHA “attributes of good performance measures.” The measure specifications were adopted for those performance measures that meet these criteria. Such measures have established validity, reliability, and feasibility and will form the foundation of the ACC/AHA measurement sets. Furthermore, writing committees are encouraged to identify additional performance measures that correspond to those key areas of quality proven to improve patient outcomes.ACC/AHA Performance Measurement Sets are to be applied in either the inpatient and/or outpatient setting depending upon the topic. Although inpatient measures have traditionally been captured by retrospective data collection, the increased use of electronic medical records allows for prospective collection in the inpatient and outpatient settings. Prospective data collection is itself a continuous quality improvement process. The performance measures quantify explicit actions performed in carefully specified patients for whom adherence should be advocated in all but the most unusual circumstances. In addition, the measures are constructed with the intent to facilitate both retrospective and prospective data collection using explicit administrative and/or easily documented clinical criteria. Furthermore, the data elements required to construct the performance measures are identified and linked to existing ACC/AHA Clinical Data Standards to encourage the standardization of cardiovascular measurement.While the focus of the performance measures writing committees is to develop measures for internal quality improvement, it is appreciated that other organizations may use these measures for external reporting of provider performance.Download figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPointDownload figureDownload PowerPoint*Immediate past Task Force Chair.†Former Task Force Member.This document was approved by the American College of Cardiology Board of Trustees in October 2005 and the American Heart Association Science Advisory and Coordinating Committee in October 2005.When citing this document, the American Heart Association would appreciate the following citation format: Krumholz HM, Anderson JL, Brooks NH, Fesmire FM, Lambrew CT, Landrum MB, Weaver WD, Whyte J. ACC/AHA clinical performance measures for adults with ST-elevation and non–ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on Performance Measures (ST-Elevation and Non–ST-Elevation Myocardial Infarction Performance Measures Writing Committee). Circulation. 2006;113:732–761. Published online before print January 3, 2006. DOI: 10.1161/CIRCULATIONAHA.106.172860.This document has been copublished in the January 3, 2006, issue of the Journal of the American College of Cardiology.Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Single copies of this document as published in the January 3, 2006, issue of the Journal of the American College of Cardiology and the February 7, 2006, issue of Circulation are available for $10.00 each by calling 1-800-253-4636 or writing the American College of Cardiology Foundation, Resource Center, at 9111 Old Georgetown Road, Bethesda, Maryland 20814-1699. To purchase bulk reprints specify reprint number—71-0350 for the published document: Up to 999 copies, call 1-800-611-6083 (U.S. only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: [email protected]Permissions: Copies, modification, alteration, enhancement and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please direct requests to [email protected] Previous Back to top Next FiguresReferencesRelatedDetailsCited By Montoy J, Shen Y and Hsia R (2022) Trends in Inequities in the Treatment of and Outcomes for Women and Minorities with Myocardial Infarction, Annals of Emergency Medicine, 10.1016/j.annemergmed.2022.04.003, Online publication date: 1-Jun-2022. Ben-Haim G, Zabatani A, Orion D, Leshem E, Irony A and Katorza E (2021) The Pandemic's impacts on patients without Covid-19 on multidisciplinary aspects in emergency medicine care, Internal and Emergency Medicine, 10.1007/s11739-021-02680-5, 16:8, (2261-2268), Online publication date: 1-Nov-2021. Desta L, Khedri M, Jernberg T, Andell P, Mohammad M, Hofman‐Bang C, Erlinge D, Spaak J and Persson H (2020) Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction, ESC Heart Failure, 10.1002/ehf2.13079, 8:1, (344-355), Online publication date: 1-Feb-2021. Appold B, Soniega-Sherwood J, Persaud R, Moss R, Ramnarine M, LaVine S, Bhansali R, Ahn S and Richman M Reining in Unnecessary Admission EKGs: A Successful Interdepartmental High-Value Care Initiative, Cureus, 10.7759/cureus.18351 Wang P, Wang Y, Peng H, Wang J, Zheng Q, Wang P, Wang J, Zhang H, Huang Y, Xiong L, Zhang R, Xia Y, Wang Q and Xu C (2021) Functional rare variant in a C/EBP beta binding site in NINJ2 gene increases the risk of coronary artery disease, Aging, 10.18632/aging.203755, 13:23, (25393-25407), Online publication date: 15-Dec-2021. France D, Levin S, Ding R, Hemphill R, Han J, Russ S, Aronsky D and Weinger M (2016) Factors Influencing Time-Dependent Quality Indicators for Patients With Suspected Acute Coronary Syndrome, Journal of Patient Safety, 10.1097/PTS.0000000000000242, 16:1, (e1-e10), Online publication date: 1-Mar-2020. Davis F, Sutzko D, Smith M, Gallagher K, Henke P and Osborne N (2020) Variation in Hospital Door-to-Intervention Time for Ruptured AAAs and Its Association with Outcomes, Annals of Vascular Surgery, 10.1016/j.avsg.2019.05.009, 62, (83-91), Online publication date: 1-Jan-2020. Watanabe I, Tatebe J, Fujii T, Noike R, Saito D, Koike H, Yabe T, Okubo R, Nakanishi R, Amano H, Toda M, Ikeda T and Morita T (2019) Prognostic Utility of Indoxyl Sulfate for Patients with Acute Coronary Syndrome, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.44149, 26:1, (64-71), Online publication date: 1-Jan-2019. Watanabe I, Tatebe J, Fujii T, Noike R, Saito D, Koike H, Yabe T, Okubo R, Nakanishi R, Amano H, Toda M, Ikeda T and Morita T (2019) Prognostic Significance of Serum Indoxyl Sulfate and Albumin for Patients with Cardiovascular Disease, International Heart Journal, 10.1536/ihj.18-116, 60:1, (129-135), Online publication date: 31-Jan-2019. Fujita K, Moles R and Chen T (2018) Quality indicators for responsible use of medicines: a systematic review, BMJ Open, 10.1136/bmjopen-2017-020437, 8:7, (e020437), Online publication date: 1-Jul-2018. Kang J, Yu J, Choi J, Chung I, Pyun W, Kim S, Lee E, Han N, Yoon J, Oh J and Rhie S (2018) Development and clinical application of an evidence-based pharmaceutical care service algorithm in acute coronary syndrome, Journal of Clinical Pharmacy and Therapeutics, 10.1111/jcpt.12665, 43:3, (366-376), Online publication date: 1-Jun-2018. Shavadia J, French W, Hellkamp A, Thomas L, Bates E, Manoukian S, Kontos M, Suter R, Henry T, Dauerman H and Roe M (2018) Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program, American Heart Journal, 10.1016/j.ahj.2017.10.017, 197, (9-17), Online publication date: 1-Mar-2018. Bebb O, Hall M and Gale C (2018) Quality Indicators for the Management of Acute Myocardial Infarction Encyclopedia of Cardiovascular Research and Medicine, 10.1016/B978-0-12-809657-4.99753-9, (230-239), . Bebb O (2018) OBSOLETE: Quality Indicators for the Management of Acute Myocardial Infarction Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.99753-8, . Lana M, Beaton A, Brant L, Bozzi I, de Magalhães O, Castro L, da Silva Júnior F, da Silva J, Ribeiro A and Nascimento B (2017) Factors associated with compliance to AHA/ACC performance measures in a myocardial infarction system of care in Brazil, International Journal for Quality in Health Care, 10.1093/intqhc/mzx059, 29:4, (499-506), Online publication date: 1-Aug-2017., Online publication date: 1-Aug-2017. Wechsler L, Demaerschalk B, Schwamm L, Adeoye O, Audebert H, Fanale C, Hess D, Majersik J, Nystrom K, Reeves M, Rosamond W and Switzer J (2016) Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association, Stroke, 48:1, (e3-e25), Online publication date: 1-Jan-2017. Yin D, Naji D, Xia Y, Li S, Bai Y, Jiang G, Zhao Y, Wang X, Huang Y, Chen S, Fa J, Tan C, Zhou M, Zhou Y, Wang L, Liu Y, Chen F, Liu J, Chen Q, Tu X, Xu C and Wang Q (2017) Genomic Variant in IL-37 Confers A Significant Risk of Coronary Artery Disease, Scientific Reports, 10.1038/srep42175, 7:1, Online publication date: 1-Mar-2017. Ishii M, Kaikita K, Sato K, Yamanaga K, Miyazaki T, Akasaka T, Tabata N, Arima Y, Sueta D, Sakamoto K, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K and Ogawa H (2016) Impact of aspirin on the prognosis in patients with coronary spasm without significant atherosclerotic stenosis, International Journal of Cardiology, 10.1016/j.ijcard.2016.06.157, 220, (328-332), Online publication date: 1-Oct-2016. Jones W, Clare R, Chiswell K, Perera D, French J, Kumar A, Blaxill J, Pijls N, Mills J, Ohman E and Patel M (2014) The Impact of Processes of Care on Myocardial Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction: Observations From the CRISP-AMI Trial, Clinical Cardiology, 10.1002/clc.22349, 38:1, (25-31), Online publication date: 1-Jan-2015. Jones W and Patel M (2014) The Devil Is in the Details, Circulation, 129:2, (142-144), Online publication date: 14-Jan-2014.Vigen R, Spertus J, Maddox T, Ho P, Jones P, Arnold S, Masoudi F and Bradley S (2014) Hospital-Level Variation in Angina and Mortality at 1 Year After Myocardial Infarction, Circulation: Cardiovascular Quality and Outcomes, 7:6, (851-856), Online publication date: 1-Nov-2014. Bellmunt S, Roqué M, Osorio D, Pardo H, Escudero J and Bonfill X (2014) Healthcare Quality Indicators of Peripheral Artery Disease Based on Systematic Reviews, European Journal of Vascular and Endovascular Surgery, 10.1016/j.ejvs.2014.02.001, 48:1, (60-69), Online publication date: 1-Jul-2014. Krumholz H, Normand S and Wang Y (2014) Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011, Circulation, 130:12, (966-975), Online publication date: 16-Sep-2014. Stelfox H and Straus S (2013) Measuring quality of care: considering conceptual approaches to quality indicator development and evaluation, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2013.05.017, 66:12, (1328-1337), Online publication date: 1-Dec-2013. Dong M, Liao J, Yan B, Li R, Zhang M and Yu C (2013) A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome, International Journal of Cardiology, 10.1016/j.ijcard.2012.07.007, 167:6, (2813-2819), Online publication date: 1-Sep-2013. Scholz K (2013) „Feedback intervention and treatment times in ST-elevation myocardial infarction“Feedback intervention and treatment times in ST-elevation myocardial infarction, Notfall + Rettungsmedizin, 10.1007/s10049-013-1695-9, 16:4, (260-268), Online publication date: 1-Jun-2013. Stelfox H and Straus S (2013) Measuring quality of care: considering measurement frameworks and needs assessment to guide quality indicator development, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2013.05.018, 66:12, (1320-1327), Online publication date: 1-Dec-2013. Silvain J, Vignalou J, Beygui F, O’Connor S, Barthélémy O, Boccara F, Ecollan P, Collet J, Assayag P and Montalescot G (2012) Impact of transfer time on mortality in acute coronary syndrome with ST-segment elevation treated by angioplasty, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2012.07.007, 105:12, (639-648), Online publication date: 1-Dec-2012. Bonow R, Ganiats T, Beam C, Blake K, Casey D, Goodlin S, Grady K, Hundley R, Jessup M, Lynn T, Masoudi F, Nilasena D, Piña I, Rockswold P, Sadwin L, Sikkema J, Sincak C, Spertus J, Torcson P, Torres E, Williams M and Wong J (2012) ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure, Circulation, 125:19, (2382-2401), Online publication date: 15-May-2012. Cram P, House J, Messenger J, Piana R, Horwitz P and Spertus J (2012) Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®, American Heart Journal, 10.1016/j.ahj.2011.08.024, 163:2, (214-221.e1), Online publication date: 1-Feb-2012. Milani R, Lavie C and Dornelles A (2012) The impact of achieving perfect care in acute coronary syndrome: The role of computer assisted decision support, American Heart Journal, 10.1016/j.ahj.2012.04.004, 164:1, (29-34), Online publication date: 1-Jul-2012. Kötter T, Blozik E and Scherer M (2012) Methods for the guideline-based development of quality indicators--a systematic review, Implementation Science, 10.1186/1748-5908-7-21, 7:1, Online publication date: 1-Dec-2012. Ranasinghe I, Naoum C, Aliprandi-Costa B, Sindone A, Steg P, Elliott J, McGarity B, Lefkovits J and Brieger D (2014) Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007, European Journal of Heart Failure, 10.1093/eurjhf/hfs041, 14:5, (464-472), Online publication date: 1-May-2012. Leonardi S, Chen A, Gharacholou S, Wang T, de Lemos J, Saucedo J, Peterson E and Roe M (2012) Limitations of using cardiac catheterization rates to assess the quality of care for patients with non–ST-segment elevation myocardial infarction, American Heart Journal, 10.1016/j.ahj.2012.07.005, 164:4, (502-508), Online publication date: 1-Oct-2012. Bajaj S, Parikh R, Gupta N, Aldehneh A, Rosenberg M, Hamdan A and Bikkina M (2012) “Code STEMI” Protocol Helps in Achieving Reduced Door-to-balloon Times in Patients Presenting with Acute ST-segment Elevation Myocardial Infarction during Off-hours, The Journal of Emergency Medicine, 10.1016/j.jemermed.2011.03.014, 42:3, (260-266), Online publication date: 1-Mar-2012. Morrow D, Fang J, Fintel D, Granger C, Katz J, Kushner F, Kuvin J, Lopez-Sendon J, McAreavey D, Nallamothu B, Page R, Parrillo J, Peterson P and Winkelman C (2012) Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models, Circulation, 126:11, (1408-1428), Online publication date: 11-Sep-2012. Sun H, Liu M and Hou S (2011) Quality indicators for acute myocardial infarction care in China, International Journal for Quality in Health Care, 10.1093/intqhc/mzr020, 23:4, (365-374), Online publication date: 1-Aug-2011. Drozda J, Messer J, Spertus J, Abramowitz B, Alexander K, Beam C, Bonow R, Burkiewicz J, Crouch M, Goff D, Hellman R, James T, King M, Machado E, Ortiz E, O'Toole M, Persell S, Pines J, Rybicki F, Sadwin L, Sikkema J, Smith P, Torcson P and Wong J (2011) ACCF/AHA/AMA–PCPI 2011 Performance Measures for Adults With Coronary Artery Disease and Hypertension, Circulation, 124:2, (248-270), Online publication date: 12-Jul-2011. Smith K and Hayward R (2011) Performance Measurement in Chronic Kidney Disease, Journal of the American Society of Nephrology, 10.1681/ASN.2010111152, 22:2, (225-234), Online publication date: 1-Feb-2011. Wijeysundera H, Mitsakakis N, Witteman W, Paulden M, van der Velde G, Tu J, Lee D, Goodman S, Petrella R, O'Flaherty M, Capewell S and Krahn M (2011) Achieving Quality Indicator Benchmarks and Potential Impact on Coronary Heart Disease Mortality, Canadian Journal of Cardiology, 10.1016/j.cjca.2011.06.005, 27:6, (756-762), Online publication date: 1-Nov-2011. Bonow R, Douglas P, Buxton A, Cohen D, Curtis J, DeLong E, Drozda J, Ferguson T, Heidenreich P, Hendel R, Masoudi F, Peterson E and Taylor A (2011) ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology, Circulation, 124:13, (1483-1502), Online publication date: 27-Sep-2011. Aragam K, Moscucci M, Smith D, Riba A, Zainea M, Chambers J, Share D and Gurm H (2011) Trends and disparities in referral to cardiac rehabilitation after percutaneous coronary intervention, American Heart Journal, 10.1016/j.ahj.2010.11.016, 161:3, (544-551.e2), Online publication date: 1-Mar-2011. (2011) Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“German-Austrian S3 guideline “Diagnosis, monitoring and therapy of cardiogenic shock due to myocardial infarction”, Intensivmedizin und Notfallmedizin, 10.1007/s00390-011-0284-8, 48:4, (291-344), Online publication date: 1-May-2011. Kozak M and Chambers C (2011) Cardiac Catheterization Laboratory Kaplan's Cardiac Anesthesia: The Echo Era, 10.1016/B978-1-4377-1617-7.00003-0, (33-73), . Goldberger J, Bonow R, Cuffe M, Dyer A, Rosenberg Y, O'Rourke R, Shah P and Smith S (2010) β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing, American Heart Journal, 10.1016/j.ahj.2010.06.023, 160:3, (435-442.e1), Online publication date: 1-Sep-2010. Schopfer D, Patel V, Chiang J and Kao J (2015) Hospitals with Percutaneous Coronary Intervention Capability Have Greater Adherence to Established Myocardial Infarction Guidelines, Hospital Practice, 10.3810/hp.2010.04.289, 38:2, (9-13), Online publication date: 1-Apr-2010. Lee L and Foody J (2010) Preventive Cardiology Cardiology Secrets, 10.1016/B978-032304525-4.00050-2, (321-325), . Thomas R, King M, Lui K, Oldridge N, Piña I and Spertus J (2010) AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services, Circulation, 122:13, (1342-1350), Online publication date: 28-Sep-2010. Chiostri M, Valente S, Crudeli E, Giglioli C and Gensini G (2010) A new post-PCI scoring system for in-hospital mortality in STEMI patients, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e328339d910, 11:10, (733-738), Online publication date: 1-Oct-2010. Sales A, Tipton E, Levine D, Houston T, Kim Y, Allison J and Kiefe C (2009) Are Co-Morbidities Associated with Guideline Adherence? The MI-Plus Study of Medicare Patients, Journal of General Internal Medicine, 10.1007/s11606-009-1096-4, 24:11, (1205-1210), Online publication date: 1-Nov-2009. Lai C, Fan C, Liao P, Tsai K, Yang C, Chu S and Chien K (2009) Impact of an Audit Program and Other Factors on Door-to-balloon Times in Acute ST-elevation Myocardial Infarction Patients Destined for Primary Coronary Intervention, Academic Emergency Medicine, 10.1111/j.1553-2712.2009.00372.x, 16:4, (333-342), Online publication date: 1-Apr-2009. Parkosewich J (2008) Cardiac Rehabilitation Barriers and Opportunities Among Women With Cardiovascular Disease, Cardiology in Review, 10.1097/CRD.0b013e31815aff8b, 16:1, (36-52), Online publication date: 1-Jan-2008. Nallamothu B (2008) Interhospital Transfer for Primary PCI Reperfusion Therapy for Acute Myocardial Infarction, 10.3109/9781420019179.011, (167-175), Online publication date: 1-Mar-2008. Goldberger J, Bonow R, Cuffe M, Dyer A, Greenland P, Rosenberg Y, O'Rourke R, Shah P and Smith S (2008) Post–myocardial infarction β-blocker therapy: The bradycardia conundrum. Rationale and design for the Pacemaker & β-blocker therapy post-MI (PACE-MI) trial, American Heart Journal, 10.1016/j.ahj.2007.10.041, 155:3, (455-464), Online publication date: 1-Mar-2008. Nguyen J, Berger A, Duval S and Luepker R (2008) Gender disparity in cardiac procedures and medication use for acute myocardial infarction, American Heart Journal, 10.1016/j.ahj.2007.11.036, 155:5, (862-868), Online publication date: 1-May-2008. Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M and Roncon L (2008) Peculiar angiographic predictors of impending left ventricular rupture after primary coronary angioplasty, Cardiovascular Revascularization Medicine, 10.1016/j.carrev.2007.12.005, 9:4, (235-237), Online publication date: 1-Oct-2008. Gimple S and Menon V (2008) Lack of Benefit With Percutaneous Intervention for Late Persistent Occlusion After Myocardial Infarction, Journal of Cardiovascular Nursing, 10.1097/01.JCN.0000305055.58129.35, 23:1, (30-33), Online publication date: 1-Jan-2008. Cresci S, Jones P, Sucharov C, Marsh S, Lanfear D, Garsa A, Courtois M, Weinheimer C, Wu J, Province M, Kelly D, McLeod H and Spertus J (2008) Interaction between PPARA genotype and β-blocker treatment influences clinical outcomes following acute coronary syndromes , Pharmacogenomics, 10.2217/14622416.9.10.1403, 9:10, (1403-1417), Online publication date: 1-Oct-2008. Koyanagi R, Hagiwara N, Kasanuki H, Tsurumi Y, Ogawa H and on behalf of the HIJAMI investigators (2008) Primary Percutaneous Coronary Intervention vs Conservative Treatment for Acute ST Elevation Myocardial Infarction Short- and Long-Term Follow-up According to Disease Severity, Circulation Journal, 10.1253/circj.CJ-07-0712, 72:9, (1391-1396), . McConnell K, Denham A and Olson K (2008) Pharmacist-Led Interventions for the Management of Cardiovascular Disease, Disease Management & Health Outcomes, 10.2165/00115677-200816030-00001, 16:3, (131-144), . Westrick R, Winn M and Eitzman D (2007) Murine Models of Vascular Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, 27:10, (2079-2093), Online publication date: 1-Oct-2007. Miller C, Roe M, Mulgund J, Hoekstra J, Santos R, Pollack C, Ohman E, Gibler W and Peterson E (2007) Impact of Acute Beta-Blocker Therapy for Patients with Non–ST-Segment Elevation Myocardial Infarction, The American Journal of Medicine, 10.1016/j.amjmed.2007.04.016, 120:8, (685-692), Online publication date: 1-Aug-2007. Dixon S, Grines C and O’Neill W (2007) The Year in Interventional Cardiology, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.04.034, 50:3, (270-285), Online publication date: 1-Jul-2007. Nallamothu B, Wang Y, Bradley E, Ho K, Curtis J, Rumsfeld J, Masoudi F and Krumholz H (2007) Comparing Hospital Performance in Door-to-Balloon Time Between the Hospital Quality Alliance and the National Cardiovascular Data Registry, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.07.010, 50:15, (1517-1519), Online publication date: 1-Oct-2007. Vinson D, Magid D, Brand D, Masoudi F, Ho P, Lyons E, Crounse L, van der Vlugt T, Padgett T, Tricomi A, Go A and Rumsfeld J (2007) Patient sex and quality of ED care for patients with myocardial infarction, The American Journal of Emergency Medicine, 10.1016/j.ajem.2007.02.049, 25:9, (996-1003), Online publication date: 1-Nov-2007. Bottorff M, Nutescu E and Spinler S (2007) Antiplatelet Therapy in Patients with Unstable Angina and Non–ST-Segment-Elevation Myocardial Infarction: Findings from the CRUSADE National Quality Improvement Initiative, Pharmacotherapy, 10.1592/phco.27.8.1145, 27:8, (1145-1162), Online publication date: 1-Aug-2007. Nallamothu B, Blaney M, Morris S, Parsons L, Miller D, Canto J, Barron H and Krumholz H (2007) Acute Reperfusion Therapy in ST-Elevation Myocardial Infarction from 1994-2003, The American Journal of Medicine, 10.1016/j.amjmed.2007.01.028, 120:8, (693.e1-693.e8), Online publication date: 1-Aug-2007. Bradley E, Nallamothu B, Curtis J, Webster T, Magid D, Granger C, Moscucci M and Krumholz H (2007) Summary of Evidence Regarding Hospital Strategies to Reduce Door-to-Balloon Times for Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention, Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 10.1097/HPC.0b013e31812da7bc, 6:3, (91-97), Online publication date: 1-Sep-2007. Masoudi F (2007) Statins for Ischemic Systolic Heart Failure, New England Journal of Medicine, 10.1056/NEJMe0707221, 357:22, (2301-2304), Online publication date: 29-Nov-2007. Dhruva V, Abdelhadi S, Anis A, Gluckman W, Hom D, Dougan W, Kaluski E, Haider B and Klapholz M (2007) ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction (STAT-MI) Trial, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.04.049, 50:6, (509-513), Online publication date: 1-Aug-2007. Fiotti N, Altamura N, Fisicaro M, Carraro N, Uxa L, Grassi G, Torelli L, Gobbato R, Guarnieri G, Baxter B and Giansante C (2006) MMP-9 Microsatellite Polymorphism and Susceptibility to Carotid Arteries Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, 26:6, (1330-1336), Online publication date: 1-Jun-2006. Amin A (2006) Improving the management of patients after myocardial infarction, from admission to discharge, Clinical Therapeutics, 10.1016/j.clinthera.2006.10.022, 28:10, (1509-1539), Online publication date: 1-Oct-2006. Douglas P, Eckel R, Gray D, Loeb J and Straube B (2006) Coming Together to Achieve Quality Cardiovascular Care, Circulation, 10.1161/CIRCULATIONAHA.106.172861, 113:5, (607-608), Online publication date: 7-Feb-2006. Spinler S (2006) ST-Segment–Elevation Myocardial Infarction: Guidelines and the Challenge of Real-World Patient Care, Pharmacotherapy, 10.1592/phco.26.8part2.115S, 26:8part2, (115S-122S), Online publication date: 1-Aug-2006. Moscucci M and Eagle K (2006) Reducing the Door-to-Balloon Time for Myocardial Infarction with ST-Segment Elevation, New England Journal of Medicine, 10.1056/NEJMe068255, 355:22, (2364-2365), Online publication date: 30-Nov-2006. Zheng H, Li Y, Zucker I and Patel K (2006) Exercise training improves renal excretory responses to acute volume expansion in rats with heart failure, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00501.2005, 291:6, (F1148-F1156), Online publication date: 1-Dec-2006. Stenberg T, Kildal A, Sanden E, How O, Hagve M, Ytrehus K, Larsen T, Myrmel T and Raju R (2014) The Acute Phase of Experimental Cardiogenic Shock Is Counteracted by Microcirculatory and Mitochondrial Adaptations, PLoS ONE, 10.1371/journal.pone.0105213, 9:9, (e105213) Mizuno M, Tomizawa A, Ohno K, Jakubowski J, Sugidachi A and Miyata T (2016) A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats, PLOS ONE, 10.1371/journal.pone.0154661, 11:4, (e0154661) Related articlesCorrectionCirculation. 2006;113:e767-e767 February 7, 2006Vol 113, Issue 5 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.106.172860 Originally publishedJanuary 3, 2006 PDF download Advertisement